Market Closed -
OTC Markets
02:01:53 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.061
USD
|
0.00%
|
|
-6.44%
|
-28.24%
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
63.87
|
22.24
|
11.05
|
19.36
|
6.854
|
8.049
|
Enterprise Value (EV)
1 |
65.98
|
27.03
|
19.42
|
27.86
|
14.81
|
16.21
|
P/E ratio
|
-13.8
x
|
-4.45
x
|
-15.6
x
|
-20
x
|
-28.1
x
|
-85
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
1,923,173,729
x
|
21,940,420
x
|
9,542,303
x
|
2,341,040
x
|
3,153,886
x
|
EV / Revenue
|
-
|
2,337,666,984
x
|
38,574,296
x
|
13,734,492
x
|
5,058,436
x
|
6,352,394
x
|
EV / EBITDA
|
-32.7
x
|
-7.97
x
|
74.6
x
|
56.3
x
|
15.9
x
|
15.2
x
|
EV / FCF
|
-13
x
|
-5.97
x
|
18.1
x
|
-546
x
|
50.2
x
|
49.7
x
|
FCF Yield
|
-7.69%
|
-16.8%
|
5.53%
|
-0.18%
|
1.99%
|
2.01%
|
Price to Book
|
9.84
x
|
3.65
x
|
1.9
x
|
3.51
x
|
1.18
x
|
1.41
x
|
Nbr of stocks (in thousands)
|
21,010
|
23,410
|
23,505
|
24,196
|
24,392
|
24,392
|
Reference price
2 |
3.040
|
0.9500
|
0.4700
|
0.8000
|
0.2810
|
0.3300
|
Announcement Date
|
1/15/19
|
1/14/20
|
12/21/20
|
12/6/21
|
12/29/22
|
12/22/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.0116
|
0.5035
|
2.029
|
2.928
|
2.552
|
EBITDA
1 |
-2.016
|
-3.391
|
0.2603
|
0.4948
|
0.9326
|
1.068
|
EBIT
1 |
-2.029
|
-3.392
|
-0.1866
|
0.0443
|
0.4827
|
0.6117
|
Operating Margin
|
-
|
-29,332.81%
|
-37.05%
|
2.18%
|
16.49%
|
23.97%
|
Earnings before Tax (EBT)
1 |
-4.433
|
-4.904
|
-0.7093
|
-0.8629
|
-0.1732
|
-0.0948
|
Net income
1 |
-4.433
|
-4.904
|
-0.7093
|
-0.8629
|
-0.1732
|
-0.0948
|
Net margin
|
-
|
-42,404.6%
|
-140.88%
|
-42.54%
|
-5.92%
|
-3.71%
|
EPS
2 |
-0.2209
|
-0.2133
|
-0.0302
|
-0.0400
|
-0.009999
|
-0.003884
|
Free Cash Flow
1 |
-5.074
|
-4.528
|
1.074
|
-0.051
|
0.2948
|
0.3264
|
FCF margin
|
-
|
-39,158.76%
|
213.35%
|
-2.51%
|
10.07%
|
12.79%
|
FCF Conversion (EBITDA)
|
-
|
-
|
412.69%
|
-
|
31.61%
|
30.58%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/15/19
|
1/14/20
|
12/21/20
|
12/6/21
|
12/29/22
|
12/22/23
|
Fiscal Period: Settembre |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2.11
|
4.79
|
8.38
|
8.5
|
7.96
|
8.16
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-1.045
x
|
-1.414
x
|
32.18
x
|
17.19
x
|
8.531
x
|
7.647
x
|
Free Cash Flow
1 |
-5.07
|
-4.53
|
1.07
|
-0.05
|
0.29
|
0.33
|
ROE (net income / shareholders' equity)
|
-97.3%
|
-75.8%
|
-11.8%
|
-15.2%
|
-3.06%
|
-1.65%
|
ROA (Net income/ Total Assets)
|
-16.3%
|
-20%
|
-0.88%
|
0.18%
|
1.98%
|
2.5%
|
Assets
1 |
27.12
|
24.55
|
81.02
|
-466.7
|
-8.758
|
-3.791
|
Book Value Per Share
2 |
0.3100
|
0.2600
|
0.2500
|
0.2300
|
0.2400
|
0.2300
|
Cash Flow per Share
2 |
0.0100
|
0.0200
|
0.0100
|
0.0300
|
0.0500
|
0.0500
|
Capex
1 |
0.7
|
5.89
|
0.39
|
0.09
|
0.25
|
0.28
|
Capex / Sales
|
-
|
50,932.15%
|
76.76%
|
4.6%
|
8.39%
|
10.94%
|
Announcement Date
|
1/15/19
|
1/14/20
|
12/21/20
|
12/6/21
|
12/29/22
|
12/22/23
|
|
1st Jan change
|
Capi.
|
---|
| -28.24% | 1.49M | | +31.96% | 272M | | +33.74% | 261M | | +49.42% | 194M | | +44.98% | 131M | | -28.57% | 121M | | +115.91% | 119M | | 0.00% | 86.82M | | +150.00% | 75.33M | | +1.20% | 55.24M |
Medical Farming
|